Abdi Sofi Samaneh, Dabirmoghaddam Payman, Aghazadeh Kayvan, Karimi Ebrahim, Naderyan Fe'li Shadi
Amir A'lam Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Otorhinolaryngology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Iran J Otorhinolaryngol. 2024;36(6):647-654. doi: 10.22038/ijorl.2024.75846.3543.
There needs to be more unanimity in the treatment approaches for supraglottic squamous cell carcinoma. This study evaluated the survival outcomes of patients who underwent transoral laser microsurgery for this type of cancer.
This longitudinal study was conducted at a tertiary university hospital in Iran. Forty-one patients with supraglottic squamous cell carcinoma who underwent transoral laser microsurgery were included. The required data were extracted from medical records. Survival analysis using the Kaplan-Meier method was used to obtain the 5-year overall recurrence-free and laryngectomy-free survival rates.
This study included 40 males (97.6%) and one female (2.4%). The mean ± standard deviation of patients' age was 55.17±8.43 years. The 5-year overall recurrence-free survival rate in all patients was 68.0%. In contrast, 76.0% of the cases were laryngectomy-free after five years. Patients in the T1 and T3 categories had better overall and laryngectomy-free survival rates when stratifying by disease stage, respectively. The 3-year local control rates of tumor were 80.0%, 63.1%, and 82.3% for T1, T2, and T3, respectively. The larynx could be preserved in four patients (80.0%) with T1, 15 patients (57.8%) with T2, and 14 patients (82.3%) with T3.
Our results suggest that transoral laser microsurgery may result in satisfactory recurrence-free survival and good oncologic outcomes. However, considering the indication of radiotherapy in some patients, the therapeutic effects of radiotherapy are part of the survival rate observed in this study.
声门上型鳞状细胞癌的治疗方法需要更多的一致性。本研究评估了接受经口激光显微手术治疗此类癌症患者的生存结果。
本纵向研究在伊朗的一家三级大学医院进行。纳入了41例行经口激光显微手术的声门上型鳞状细胞癌患者。所需数据从病历中提取。采用Kaplan-Meier方法进行生存分析,以获得5年总无复发生存率和无喉切除术生存率。
本研究包括40名男性(97.6%)和1名女性(2.4%)。患者年龄的平均值±标准差为55.17±8.43岁。所有患者的5年总无复发生存率为68.0%。相比之下,5年后76.0%的病例未行喉切除术。按疾病分期分层时,T1和T3类别的患者分别具有更好的总生存率和无喉切除术生存率。T1、T2和T3期肿瘤的3年局部控制率分别为80.0%、63.1%和82.3%。T1期4例患者(80.0%)、T2期15例患者(57.8%)和T3期14例患者(82.3%)的喉得以保留。
我们的结果表明,经口激光显微手术可能会带来令人满意的无复发生存率和良好的肿瘤学结果。然而,考虑到一些患者的放疗指征,放疗的治疗效果是本研究中观察到的生存率的一部分。